This report can be used as a resource to support TB program performance indicator development across programs. Its results should be shared and discussed by public health personnel, federal, provincial and territorial decision‐makers, and others involved in planning and delivering TB programs in Canada.
Stream: Tuberculosis
Multi-Drug Resistant Tuberculosis – International Resources for Canadian Public Health Personnel
List of MDR-TB resources that can inform the Canadian Context [1]: 1. Multidrug-Resistant Tuberculosis (MDR-TB) Update 2017 (PDF) Infographic and fact sheet 2. The Lucky Specials: Tuberculosis Awareness Through Storytelling (2017) A film which educates viewers on the risks, prevention, and treatment of tuberculosis (TB) and MDR-TB. The Lucky Specials combines animation and live-action storytelling…
IQ13: Post-landing Surveillance and Virtual Tuberculosis Services in Alberta
In this, the fifth in our ‘TB Talk’ series of episodes, we hear from Dr. Ryan Cooper, an infectious diseases specialist with Alberta Health Services. Here, Dr. Cooper speaks to how post-landing TB surveillance works in Canada (including some Alberta-specific challenges), plus the best approach to on-going follow-up. He also discusses how Alberta’s virtual TB clinic model has made a difference to rural, remote and Indigenous communities.
IQ12 : New Digital Technologies in TB
The fourth in our ‘TB Talk’ series, conversations from the most recent meeting of the North American Region of the International Union Against Tuberculosis. This episode, we hear from Dr. Dennis Falzon, a Medical Officer with the Stop TB Department at the World Health Organization in Geneva. Here, he discusses the WHO’s End TB Strategy, as well as the potential of new technologies to prevent and eliminate TB.
IQ11: The Social Determinants of TB in Indigenous Communities (TB Talk, Pt 3)
The third in our ‘TB Talk’ series, we hear from Dr. Malcolm King, a professor in the Faculty of Health Sciences at Simon Fraser University. He discusses the importance of social determinants of health to the rate of new TB infections and better TB outcomes in remote, northern and Indigenous communities.
IQ10: Tuberculosis and Cultural Humility (TB Talk, Pt 2)
This episode continues our look at tuberculosis at End TB 2017, a meeting of the North American Region of the International Union Against Tuberculosis. Our guest, Kay Wallis, is a special projects manager with the Curry International Tuberculosis Center. She presented on cultural proficiency among healthcare providers, or, as she calls it, cultural humility.
Latent Tuberculosis Infection (LTBI) Management at BridgeCare Clinic (Full Report)
An in-depth review and analysis of the model of latent tuberculosis infection management and promising treatment completion outcomes at BridgeCare Clinic in Winnipeg, Canada.
Integrated LTBI Care for Refugees: Successes & Challenges at BridgeCare Clinic in Winnipeg
In this case study, we share the story of the success of BridgeCare Clinic, a model of integrated TB services for government-assisted refugees for its approach to improving latent tuberculosis infection (LTBI) treatment completion outcomes in priority populations.
IQ9: Tuberculosis priorities at End TB 2017 (TB Talk, Pt 1)
This episode, we turn our attention to tuberculosis. This February, the city of Vancouver played host to End TB 2017, a meeting of the International Union Against Tuberculosis, specifically, the North American Region. We hear a sample of attendees’ top TB priorities. In future episodes, we’ll bring you a number of one-on-one conversations with experts at the meeting.
Tuberculosis
In 2016, NCCID consulted practitioners, policy makers and researchers to identify key gaps and map opportunities where improved knowledge translation and exchange can be applied to practice and policy towards TB control and elimination. Based on what we heard, we are undertaking a series of new projects.
Treatment as Prevention: Containment of TB, HIV and Hep C during the next decade
Join three of Canada’s prominent physicians, Drs. Allan Ronald, Joel Kettner and Julio Montaner, for a webinar that explores the topic of Treatment as Prevention for TB, Hepatitis C and HIV/AIDS.
Mycobacterium Tuberculosis Surveillance in Canada